Insiders · Profile

Sanna Bastiano

EVP, Cell & Genetic Therapies at Vertex Pharmaceuticals. Filing since 11 Feb 2021. CIK 0001829069

Company

Date

Role

Action

Shares

Amount

Of holding

VRTX Vertex Pharmaceuticals

8 May 2023

EVP, Cell & Genetic Therapies

Sold on a plan

2,850

$997.50K

8.2%

VRTX Vertex Pharmaceuticals

5 May 2023

EVP, Cell & Genetic Therapies

Sold on a plan

422

$147.71K

1.2%

VRTX Vertex Pharmaceuticals

3 May 2023

EVP, Cell & Genetic Therapies

Sold on a plan

2,781

$975.42K

7.3%

VRTX Vertex Pharmaceuticals

2 May 2023

EVP, Cell & Genetic Therapies

Sold on a plan

1,622

$568.77K

4.1%

VRTX Vertex Pharmaceuticals

12 Apr 2023

EVP, Cell & Genetic Therapies

Sold on a plan

7,567

$2.47M

16.0%

VRTX Vertex Pharmaceuticals

4 Apr 2023

EVP, Cell & Genetic Therapies

Sold on a plan

522

$164.85K

1.1%

VRTX Vertex Pharmaceuticals

16 Mar 2023

EVP, Cell & Genetic Therapies

Sold on a plan

2,746

$825.42K

5.3%

VRTX Vertex Pharmaceuticals

14 Feb 2023

EVP, Cell & Genetic Therapies

Sold, plan not stated

2,181

$655.16K

3.5%

VRTX Vertex Pharmaceuticals

13 Feb 2023

EVP, Cell & Genetic Therapies

Sold, plan not stated

113

$33.94K

0.2%

VRTX Vertex Pharmaceuticals

31 Jan 2023

EVP, Cell & Genetic Therapies

Sold, plan not stated

106

$34.45K

0.3%

VRTX Vertex Pharmaceuticals

2 Nov 2022

EVP, Cell & Genetic Therapies

Sold, plan not stated

320

$100.05K

0.8%

VRTX Vertex Pharmaceuticals

18 Oct 2022

EVP, Cell & Genetic Therapies

Sold, plan not stated

1,791

$537.86K

4.4%

VRTX Vertex Pharmaceuticals

16 May 2022

EVP, Cell & Genetic Therapies

Sold, plan not stated

45

$11.38K

0.1%

VRTX Vertex Pharmaceuticals

4 May 2022

EVP, Cell & Genetic Therapies

Sold, plan not stated

36

$9.90K

0.1%

VRTX Vertex Pharmaceuticals

2 May 2022

EVP, Cell & Genetic Therapies

Sold, plan not stated

320

$82.93K

0.8%

VRTX Vertex Pharmaceuticals

7 Apr 2022

EVP, Cell & Genetic Therapies

Sold, plan not stated

561

$154.93K

1.3%

VRTX Vertex Pharmaceuticals

5 Apr 2022

EVP, Cell & Genetic Therapies

Sold, plan not stated

3,163

$870.55K

6.8%

VRTX Vertex Pharmaceuticals

4 Apr 2022

EVP, Cell & Genetic Therapies

Sold, plan not stated

562

$150.45K

1.2%

VRTX Vertex Pharmaceuticals

17 Mar 2022

EVP, Cell & Genetic Therapies

Sold, plan not stated

2,122

$530.63K

4.2%

VRTX Vertex Pharmaceuticals

2 Feb 2022

EVP, Cell & Genetic Therapies

Sold, plan not stated

1,040

$261.02K

1.9%

VRTX Vertex Pharmaceuticals

17 May 2021

EVP, Cell & Genetic Therapies

Sold, plan not stated

112

$24.23K

0.3%

VRTX Vertex Pharmaceuticals

3 May 2021

EVP, Cell & Genetic Therapies

Sold, plan not stated

960

$209.69K

2.7%

VRTX Vertex Pharmaceuticals

5 Apr 2021

EVP, Cell & Genetic Therapies

Sold, plan not stated

1,686

$361.05K

4.5%

VRTX Vertex Pharmaceuticals

11 Feb 2021

EVP, Cell & Genetic Therapies

Sold, plan not stated

1,686

$355.01K

4.2%

24 decisions on file.